Current Report Filing (8-k)
21 Maio 2018 - 7:27AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): May 15, 2018
Health
Insurance Innovations, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35811
|
|
46-1282634
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
15438
N. Florida Avenue, Suite 201
Tampa,
Florida
|
|
33613
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (813) 397-1187
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
5.07.
|
Submission
of Matters to a Vote of Security Holders.
|
On
May 15, 2018, Health Insurance Innovations, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual
Meeting”). The Company previously filed with the SEC its Definitive Proxy Statement and related materials pertaining to
the Annual Meeting on April 23, 2018. On the record date of March 20, 2018 there were 12,354,498 shares of the Company’s
Class A common stock and 3,841,667 shares of the Company’s Class B common stock outstanding and eligible to vote. At the
Annual Meeting, the stockholders: (i) elected the seven persons identified below to serve as directors of the Company to hold
office until the Company’s 2019 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
and (ii) ratified the appointment of Grant Thornton LLP as the independent auditor of the Company.
Proposal
1: Election of Directors
The
final results of stockholder voting on the election of directors were as follows:
Name
|
|
Votes For
|
|
|
Votes Withheld
|
|
|
Broker
Non-Votes
|
|
Paul E. Avery
|
|
|
10,122,554
|
|
|
|
1,678,219
|
|
|
|
1,920,734
|
|
Anthony J. Barkett
|
|
|
10,088,673
|
|
|
|
1,712,100
|
|
|
|
1,920,734
|
|
Paul G. Gabos
|
|
|
9,740,602
|
|
|
|
2,060,171
|
|
|
|
1,920,734
|
|
Michael W. Kosloske
|
|
|
11,729,000
|
|
|
|
71,773
|
|
|
|
1,920,734
|
|
Gavin D. Southwell
|
|
|
11,729,456
|
|
|
|
71,317
|
|
|
|
1,920,734
|
|
Robert S. Murley
|
|
|
11,707,951
|
|
|
|
92,822
|
|
|
|
1,920,734
|
|
John A. Fichthorn
|
|
|
11,718,073
|
|
|
|
82,700
|
|
|
|
1,920,734
|
|
Proposal
2: Ratification of the appointment of Grant Thornton LLP as the Company’s Independent Auditor
The
final results of stockholder voting on the ratification of the appointment of Grant Thornton as the Company’s independent
auditor were as follows:
Votes For
|
|
|
Votes Against
|
|
|
Votes Abstain
|
|
|
Broker Non-Votes
|
|
|
13,599,097
|
|
|
|
112,424
|
|
|
|
9,986
|
|
|
|
0
|
|
The
stockholders did not vote on any other matters at the Annual Meeting.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTH
INSURANCE INNOVATIONS, INC.
|
|
|
|
|
By:
|
/s/
Michael D. Hershberger
|
|
Name:
|
Michael
D. Hershberger
|
|
Title:
|
Chief
Financial Officer
|
Date:
May 21, 2018
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Health Insurance Innovations Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Health Insurance Innovations, Inc.